Drug profile · INN
iptacopan hydrochloride hydrate
FABHALTA
iptacopan hydrochloride hydrate (FABHALTA) is a complement factor b inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iptacopan hydrochloride hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
iptacopan hydrochloride hydrate (FABHALTA) is a complement factor b inhibitor.
Key facts
INN iptacopan hydrochloride hydrate
Brand FABHALTA
Mechanism Complement factor B inhibitor
Target Complement factor B
Mechanism of action
Complement factor B inhibitor
Primary target: Complement factor B
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is iptacopan hydrochloride hydrate?
iptacopan hydrochloride hydrate (FABHALTA) is a complement factor b inhibitor.
What is the brand name for iptacopan hydrochloride hydrate?
FABHALTA is a marketed brand name for iptacopan hydrochloride hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.